These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1334113

  • 1. Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs.
    Parchment RE, Soleimanpour K, Petrose S, Murphy MJ.
    Int J Cell Cloning; 1992 Nov; 10(6):359-68. PubMed ID: 1334113
    [Abstract] [Full Text] [Related]

  • 2. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N, Morimoto H, Akita T, Inoue H, Tanaka T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [Abstract] [Full Text] [Related]

  • 3. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T, Kuraishi Y, Aiba K, Inoue K.
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH, Wang L, Lorico A, Wang RC, Brattain MG, Casazza AM.
    Cancer Res; 1991 Oct 01; 51(19):5275-83. PubMed ID: 1717144
    [Abstract] [Full Text] [Related]

  • 5. [Fundamental study and clinical testing of human tumor clonogenic assay (HTCA)].
    Sasaki Y, Saijo N, Eguchi K, Futami H, Suga J, Miyaoka H, Sano T, Sakurai M, Shinkai T, Tominaga K.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 2):1185-93. PubMed ID: 3729440
    [Abstract] [Full Text] [Related]

  • 6. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR, van der Bliek AM, Schuurhuis GJ, van der Velde-Koerts T, Smit JJ, Borst P.
    Cancer Res; 1990 Mar 15; 50(6):1779-85. PubMed ID: 1968359
    [Abstract] [Full Text] [Related]

  • 7. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin.
    Kim R, Hirabayashi N, Nishiyama M, Saeki S, Toge T, Okada K.
    Anticancer Res; 1991 Mar 15; 11(1):429-31. PubMed ID: 1850221
    [Abstract] [Full Text] [Related]

  • 8. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE.
    Gynecol Oncol; 1994 Dec 15; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [Abstract] [Full Text] [Related]

  • 9. [Update of human tumor clonogenic assay in carcinoma of the lung].
    Kanzawa F.
    Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1552-9. PubMed ID: 2992395
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 11. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.
    Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143
    [Abstract] [Full Text] [Related]

  • 12. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
    Ohnoshi T, Hiraki S.
    Gan To Kagaku Ryoho; 1985 Aug 01; 12(8):1582-7. PubMed ID: 3927847
    [Abstract] [Full Text] [Related]

  • 13. [Choice of second-line chemotherapy for advanced breast cancer based on the chemosensitivity assay by in vitro colony assay].
    Inoue K, Mukaiyama T, Yamazaki H, Horikoshi N, Ogawa M, Kobayashi T, Aiba K, Kuraishi Y.
    Gan To Kagaku Ryoho; 1986 Feb 01; 13(2):356-61. PubMed ID: 3080968
    [Abstract] [Full Text] [Related]

  • 14. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
    Cole SP, Chanda ER, Dicke FP, Gerlach JH, Mirski SE.
    Cancer Res; 1991 Jul 01; 51(13):3345-52. PubMed ID: 1675932
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N, Lam YM, Pym J, Campling BG.
    Cancer; 1996 May 01; 77(9):1797-808. PubMed ID: 8646677
    [Abstract] [Full Text] [Related]

  • 16. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
    Parker RL, Welander CE, Homesley HD, Jobson VW, Kawamoto EH.
    Obstet Gynecol; 1984 Sep 01; 64(3):412-6. PubMed ID: 6462571
    [Abstract] [Full Text] [Related]

  • 17. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ, Fisher MH, Stephenson J, Li DH, Zhou BS, Cheng YC.
    Cancer Res; 1988 Nov 01; 48(21):5956-64. PubMed ID: 2844393
    [Abstract] [Full Text] [Related]

  • 18. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
    Wolverton JS, Danks MK, Schmidt CA, Beck WT.
    Cancer Res; 1989 May 01; 49(9):2422-6. PubMed ID: 2539902
    [Abstract] [Full Text] [Related]

  • 19. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
    Kakehi Y, Wu WJ, Kim WJ, Arao S, Fukumoto M, Yoshida O.
    Int J Urol; 1995 Nov 01; 2(5):309-15. PubMed ID: 8749949
    [Abstract] [Full Text] [Related]

  • 20. Clonogenic and nonclonogenic in vitro chemosensitivity assays.
    Weisenthal LM, Lippman ME.
    Cancer Treat Rep; 1985 Jun 01; 69(6):615-32. PubMed ID: 3893692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.